Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)
Sikov, WM, Berry, DA, Perou, CM, Singh, B, Cirrincione, CT, Tolaney, SM, Somlo, G, Port, ER, Qamar, R, Sturtz, K, Mamounas, E, Golshan, M, Bellon, JR, Collyar, D, Hahn, OM, Carey, LA, Hudis, CA, Winer, EP
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
Sikov, WM, Berry, DA, Perou, CM, Singh, B, Cirrincione, C, Tolaney, S, Kuzma, CS, Pluard, TJ, Somlo, G, Port, E, Golshan, M, Bellon, JR, Collyar, D, Hahn, OM, Carey, LA, Hudis, C, Winer, EP
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
A phase II trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer
Hahn, OM, Ma, CX, Lin, L, Hou, D, Sattar, H, Olopade, FO, Nanda, R, Hoffman, PC, Naughton, MJ, Pluard, T, Watson, MA, Ellis, M, Conzen, SD, Fleming, GF
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
TBX10, a member of the Tbx1-subfamily of conserved developmental genes, is located at human chromosome 11q13 and proximal mouse chromosome 19
Law, D J, Garvey, N, Agulnik, S I, Perlroth, V, Hahn, O M, Rhinehart, R E, Gebuhr, T C, Silver, L M
Published in Mammalian genome (01.05.1998)
Published in Mammalian genome (01.05.1998)
Get full text
Journal Article